background image

Investor Relations

TissueGene, Inc. is a privately held Delaware corporation that is currently seeking additional funding in order to further accelerate the development of TG-C and the other products in its pipeline.

Contact Information

Steven Birnbaum
Director of Business development

TissueGene, Inc.
9605 Medical Center Drive, Suite 200
Rockville, MD 20850
United States

Phone: (301) 921-6000 X154
Fax: (301) 921-6011
Email: sbirnbaum@tissuegene.com